Evidence map›Paper›PMID 24285922›Full record

ArticleInternational journal of nanomedicine2013

Allergenicity and toxicology of inhaled silver nanoparticles in allergen-provocation mice models.

Hsiao-Chi Chuang, Ta-Chih Hsiao, Cheng-Kuan Wu, Hui-Hsien Chang, Chii-Hong Lee, Chih-Cheng Chang, Tsun-Jen Cheng, Taiwan CardioPulmonary Research Group (T-CPR)

Open access · goldAbstract read
In one paragraph

Article in International journal of nanomedicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.2field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 57 citations in OpenAlex.

  1. Review
  2. Article
  3. Nanotechnology-Based Therapeutics for Airway Inflammatory Diseases.Clinical reviews in allergy & immunology · 2025
    Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. The Toxicology of Engineered Nanomaterials in Asthma.Current environmental health reports · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Hsiao-Chi ChuangSchool of respiratory Therapy, College of Medicine Shuang Ho Hospital, Taipei Medical University, Taipei, Taiwan ; Division of Pulmonary Medicine, Department of Internal Medicine, Shuang Ho Hospital, Taipei Medical University, Taipei, Taiwan.
Ta-Chih Hsiao
Cheng-Kuan Wu
Hui-Hsien Chang
Chii-Hong Lee
Chih-Cheng Chang
Tsun-Jen Cheng
Taiwan CardioPulmonary Research Group (T-CPR)
National Taiwan University · TWTaipei Medical University-Shuang Ho Hospital · TWNational Central University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Silver nanoparticles (AgNP) have been associated with the exacerbation of airway hyperresponsiveness. However, the allergenicity and toxicology of AgNP in healthy and allergic individuals are unclear. We investigated the pathophysiological responses to AgNP inhalation in a murine model of asthma. Continuous and stable levels of 33 nm AgNP were maintained at 3.3 mg/m(3) during the experimental period. AgNP exposure concomitant with ovalbumin challenge increased the enhanced pause (Penh) in the control and allergic groups. AgNP evoked neutrophil, lymphocyte and eosinophil infiltration into the airways and elevated the levels of allergic markers (immunoglobulin E [IgE] and leukotriene E4 [LTE4]), the type 2 T helper (Th2) cytokine interleukin-13 (IL-13), and oxidative stress (8-hydroxy-2'-deoxyguanosine [8-OHdG]) in healthy and allergic mice. Bronchocentric interstitial inflammation was observed after AgNP inhalation. After inhalation, the AgNP accumulated predominantly in the lungs, and trivial amounts of AgNP were excreted in the urine and feces. Furthermore, the AgNP induced inflammatory responses in the peritoneum. The inhalation of AgNP may present safety concerns in healthy and susceptible individuals.

Indexed as

8-Hydroxy-2'-DeoxyguanosineAdministration, InhalationAnimalsDeoxyguanosineFemaleMetal NanoparticlesMiceMice, Inbred BALB COrgan SpecificityOvalbuminOxidative StressPneumoniaRespiratory HypersensitivitySilver8-Hydroxy-2'-DeoxyguanosineDeoxyguanosineOvalbuminSilverinductively coupled plasma-mass spectrometryinflammationleukotriene E4ovalbuminoxidative stress

Identifiers

PMID24285922
PMCPMC3841295
OpenAlexW2083363866

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.